Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 5Not yet recruiting 4Enrolling by invitation 2Completed 2Active not recruiting 2

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Other 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 552Neoplasms 502Carcinoma, Non-Small-Cell Lung 419Prostatic Neoplasms 326Colorectal Neoplasms 310Lung Neoplasms 280Neoplasm Metastasis 233Leukemia, Myeloid, Acute 222Ovarian Neoplasms 205Pancreatic Neoplasms 195Multiple Myeloma 186Recurrence 141Squamous Cell Carcinoma of Head and Neck 140Brain Neoplasms 139Stomach Neoplasms 138Melanoma 132Carcinoma, Hepatocellular 130Endometrial Neoplasms 127Glioblastoma 124Triple Negative Breast Neoplasms 116Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Hematologic Neoplasms 102Head and Neck Neoplasms 100Urinary Bladder Neoplasms 98Carcinoma, Renal Cell 98Lymphoma 97Glioma 94Sarcoma 93Esophageal Neoplasms 90Uterine Cervical Neoplasms 88

Interventions

mazdutide 1ASP3662 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Diabetes Mellitus, Type 2 × 90 days × Clear all
NCT07595718 2026-05-19

AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases

Asan Medical Center

Recruiting
1,000 enrolled
Breast

Breast Neoplasms, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Osteoarthritis, Low Back Pain

NCT07296484 2026-05-12

CAPTAIN-T2D

Sparrow Pharmaceuticals

Phase 2 Recruiting
1,500 enrolled

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

NCT05950282 2026-05-01

DAISY

Lilli Health

Recruiting
150 enrolled
Other

Diabetes Mellitus, Type 2, Hyperinsulinism, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Metabolic Syndrome

NCT06803771 2026-03-23

SAFE-D

University Hospital Southampton NHS Foundation Trust

Phase NA Recruiting
15,000 enrolled
Gastrointestinal

Pancreatic cancer, adult, Diabetes Mellitus, Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 3 Recruiting
420 enrolled
Lymphoid

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡